X
Xponance Portfolio holdings
AUM
$16.3B
Turnover
12.69%
1-Year Est. Return
44.61%
This Fund
S&P 500
This Quarter
Est. Return
-2.91%
1 Year Est. Return
+44.61%
3 Year Est. Return
+143.93%
5 Year Est. Return
+195.59%
10 Year Est. Return
+501.04%
AUM
$14.1B
AUM Growth
+$741M
(+5.6%)
Cap. Flow
+$1.58B
Cap. Flow
% of AUM
11.22%
Top 10 Holdings %
Top 10 Hldgs %
38.76%
Holding
1,735
New
165
Increased
1,464
Reduced
57
Closed
49
Avg Time Held
3.5
years
Top 10 Avg Time Held
4.8
years
Top 20 Avg Time Held
3.7
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$110M |
| 2 |
Apple
AAPL
|
+$89M |
| 3 |
Microsoft
MSFT
|
+$81.1M |
| 4 |
Amazon
AMZN
|
+$54.3M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$45.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Principal Financial Group
PFG
|
+$4.8M |
| 2 |
KeyCorp
KEY
|
+$4.08M |
| 3 |
Solstice Advanced Materials
SOLS
|
+$3.06M |
| 4 |
Valero Energy
VLO
|
+$2.61M |
| 5 |
Monster Beverage
MNST
|
+$2.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 35.95% |
| 2 | Financials | 11.04% |
| 3 | Consumer Discretionary | 10.62% |
| 4 | Communication Services | 10.59% |
| 5 | Healthcare | 9.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1201
Franklin Electric
FELE
$4.41B
| $338K | ﹤0.01% |
3,672
+594
| +19% | +$58.3K |
2022 Q3
14 quarters
|
|
1202
Hilton Grand Vacations
HGV
$2.7B
| $338K | ﹤0.01% |
8,638
+1,237
| +17% | +$55.4K |
2023 Q1
12 quarters
|
|
1203
SiriusXM
SIRI
$8.94B
| $337K | ﹤0.01% |
14,591
+4,300
| +42% | +$92.4K |
2022 Q1
16 quarters
|
|
1204
BGC Group
BGC
$5.37B
| $337K | ﹤0.01% |
34,430
+5,409
| +19% | +$50.1K |
2021 Q2
19 quarters
|
|
1205
WSFS Financial
WSFS
$3.84B
| $335K | ﹤0.01% |
5,122
+691
| +16% | +$43.6K |
2024 Q4
5 quarters
|
|
1206
United Natural Foods
UNFI
$2.88B
| $335K | ﹤0.01% |
+7,437
| New | +$285K |
2026 Q1
0 quarters
|
|
1207
Millrose Properties Inc
MRP
$3.52B
| $335K | ﹤0.01% |
11,952
+3,560
| +42% | +$107K |
2025 Q3
2 quarters
|
|
1208
StoneCo
STNE
$2.65B
| $332K | ﹤0.01% |
23,545
+3,795
| +19% | +$58.3K |
2020 Q2
23 quarters
|
|
1209
Mizuho Financial
MFG
$124B
| $332K | ﹤0.01% |
41,858
+4,760
| +13% | +$40.3K |
2023 Q3
10 quarters
|
|
1210
Constellium
CSTM
$3.44B
| $331K | ﹤0.01% |
13,476
+2,605
| +24% | +$62K |
2023 Q2
11 quarters
|
|
1211
LeMaitre Vascular
LMAT
$1.89B
| $331K | ﹤0.01% |
+3,030
| New | +$289K |
2026 Q1
0 quarters
|
|
1212
Broadstone Net Lease
BNL
$3.46B
| $330K | ﹤0.01% |
18,044
+3,016
| +20% | +$56.8K |
2023 Q1
12 quarters
|
|
1213
Oceaneering
OII
$4.33B
| $330K | ﹤0.01% |
+9,294
| New | +$301K |
2026 Q1
0 quarters
|
|
1214
DELISTED
Crinetics Pharmaceuticals
CRNX
| $328K | ﹤0.01% |
9,043
+1,848
| +26% | +$82.5K |
2024 Q2
7 quarters
|
|
1215
Liberty Live Group Series C
LLYVK
$8.95B
| $327K | ﹤0.01% |
+3,479
| New | +$313K |
2026 Q1
0 quarters
|
|
1216
Kadant
KAI
$3.06B
| $326K | ﹤0.01% |
1,115
+182
| +20% | +$58.5K |
2024 Q1
8 quarters
|
|
1217
Avista
AVA
$3.06B
| $325K | ﹤0.01% |
8,105
+1,689
| +26% | +$68.2K |
2024 Q4
5 quarters
|
|
1218
UL Solutions
ULS
$14.5B
| $325K | ﹤0.01% |
3,793
+523
| +16% | +$41.2K |
2025 Q4
1 quarter
|
|
1219
Spyre Therapeutics
SYRE
$7.35B
| $325K | ﹤0.01% |
+6,445
| New | +$243K |
2026 Q1
0 quarters
|
|
1220
DELISTED
National Storage Affiliates Trust
NSA
| $325K | ﹤0.01% |
+8,600
| New | +$291K |
2026 Q1
0 quarters
|
|
1221
ScottsMiracle-Gro
SMG
$2.89B
| $324K | ﹤0.01% |
5,335
+1,252
| +31% | +$81K |
2020 Q2
23 quarters
|
|
1222
Cal-Maine
CALM
$2.95B
| $324K | ﹤0.01% |
4,094
+587
| +17% | +$48.2K |
2024 Q2
7 quarters
|
|
1223
Sarepta Therapeutics
SRPT
$1.78B
| $323K | ﹤0.01% |
14,842
+2,342
| +19% | +$45.3K |
2020 Q2
23 quarters
|
|
1224
Shake Shack
SHAK
$2.78B
| $323K | ﹤0.01% |
3,649
+587
| +19% | +$54K |
2024 Q1
8 quarters
|
|
1225
Renasant Corp
RNST
$3.56B
| $322K | ﹤0.01% |
8,926
+1,479
| +20% | +$55.6K |
2025 Q2
3 quarters
|
|
Similar funds
PCM
LPC
MFG
PAM
BS
BBVA
NMO
PAS
Xponance's Q1 2026 Portfolio in Review
As of Q1 2026, Xponance held 1,735 positions worth $14.1B, up 5.6% from $13.3B the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Xponance deployed $1.58B of net new capital in Q1 2026, opening 165 new positions and adding to 1,464 existing holdings. Its largest new stake was Medline Inc: 22,732 shares worth $1.01M.
By sector, the portfolio is most concentrated in Technology at 36% of assets, down from 38% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Principal Financial Group, an estimated $4.8M trimmed.
- Xponance's largest Q1 2026 buy was Medline Inc: 22,732 shares worth $1.01M.
- Xponance added most to NVIDIA in Q1 2026, an estimated $110M increase.
- Xponance's biggest Q1 2026 reduction was Principal Financial Group, cutting an estimated $4.8M.
- Xponance fully exited Confluent in Q1 2026, selling an estimated $1.34M.
- Xponance's ten largest holdings make up 39% of its $14.1B portfolio in Q1 2026.
- Xponance opened 165 new positions and closed 49 in Q1 2026.
- Xponance's portfolio value rose 5.6% quarter-over-quarter to $14.1B.
Based on Xponance's 13F filing for Q1 2026, filed 13 May 2026.